Argatroban, aspirin and clopidgrel combination therapy for non-cardioembolic acute ischemic stroke -a prospective, randomized, argatroban and aspirin-controlled study
Not Applicable
- Conditions
- Acute non-cardioembolic stroke
- Registration Number
- JPRN-UMIN000014405
- Lead Sponsor
- Department of Neurology Okazaki City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. cardioembolic stroke 2. antithrombotic therapy (cilostazol, ticlopidine, aspirin 100mg over, clopidogrel 75mg over, anticoagulants) before onset 3. congestive heart failure 4. medical history of allergies of argatroban, aspirin, clopidogrel 5. blood pressure cannot be controlled below 180/105mmHg 6. high hemorrhagic risk 7. severe stenosis of major cerebral and cervical artery 8. patients who are not appropriate to participate in this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method